216 related articles for article (PubMed ID: 21316136)
21. Bisphosphonate-associated osteonecrosis of the jaw: a literature review and clinical practice guidelines.
Pickett FA;
J Dent Hyg; 2006; 80(3):10. PubMed ID: 16953991
[TBL] [Abstract][Full Text] [Related]
22. Bisphosphonate-induced avascular osteonecrosis of the jaws: a clinical report of 11 cases.
Dimitrakopoulos I; Magopoulos C; Karakasis D
Int J Oral Maxillofac Surg; 2006 Jul; 35(7):588-93. PubMed ID: 16687238
[TBL] [Abstract][Full Text] [Related]
23. Atraumatic extraction of a non-vital tooth in a patient receiving long-term oral bisphosphonates.
Xiong M; Pearson A; Sabino M; Svoboda L; Ehlis E
Northwest Dent; 2010; 89(4):27-33. PubMed ID: 20860270
[No Abstract] [Full Text] [Related]
24. Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure.
Hutchinson M; O'Ryan F; Chavez V; Lathon PV; Sanchez G; Hatcher DC; Indresano AT; Lo JC
J Oral Maxillofac Surg; 2010 Sep; 68(9):2232-40. PubMed ID: 20728032
[TBL] [Abstract][Full Text] [Related]
25. Atraumatic teeth extraction in bisphosphonate-treated patients.
Regev E; Lustmann J; Nashef R
J Oral Maxillofac Surg; 2008 Jun; 66(6):1157-61. PubMed ID: 18486780
[TBL] [Abstract][Full Text] [Related]
26. Perioperative antibiotic regimen in rats treated with pamidronate plus dexamethasone and subjected to dental extraction: a study of the changes in the jaws.
López-Jornet P; Camacho-Alonso F; Martínez-Canovas A; Molina-Miñano F; Gómez-García F; Vicente-Ortega V
J Oral Maxillofac Surg; 2011 Oct; 69(10):2488-93. PubMed ID: 21798645
[TBL] [Abstract][Full Text] [Related]
27. Letter to the editor.
Ehrmann EH
Aust Endod J; 2010 Aug; 36(2):96. PubMed ID: 20666758
[No Abstract] [Full Text] [Related]
28. Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws.
Kunchur R; Need A; Hughes T; Goss A
J Oral Maxillofac Surg; 2009 Jun; 67(6):1167-73. PubMed ID: 19446200
[TBL] [Abstract][Full Text] [Related]
29. Clinical characterization might help in preventing osteonecrosis of the jaw.
Kyrgidis A; Andreadis C
Clin Cancer Res; 2008 Dec; 14(24):8321; author reply 8321-2. PubMed ID: 19088052
[No Abstract] [Full Text] [Related]
30. Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review.
Nicolatou-Galitis O; Razis E; Galiti D; Galitis E; Labropoulos S; Tsimpidakis A; Sgouros J; Karampeazis A; Migliorati C
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Dec; 120(6):699-706. PubMed ID: 26455289
[TBL] [Abstract][Full Text] [Related]
31. Dental and periodontal history of oncologic patients on parenteral bisphosphonates with or without osteonecrosis of the jaws: a pilot study.
Carmagnola D; Celestino S; Abati S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Dec; 106(6):e10-5. PubMed ID: 18801674
[TBL] [Abstract][Full Text] [Related]
32. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.
Vahtsevanos K; Kyrgidis A; Verrou E; Katodritou E; Triaridis S; Andreadis CG; Boukovinas I; Koloutsos GE; Teleioudis Z; Kitikidou K; Paraskevopoulos P; Zervas K; Antoniades K
J Clin Oncol; 2009 Nov; 27(32):5356-62. PubMed ID: 19805682
[TBL] [Abstract][Full Text] [Related]
33. Dental extractions and bisphosphonates: the assessment, consent and management, a proposed algorithm.
Malden N; Beltes C; Lopes V
Br Dent J; 2009 Jan; 206(2):93-8. PubMed ID: 19165270
[TBL] [Abstract][Full Text] [Related]
34. Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid.
García Sáenz JA; López Tarruella S; García Paredes B; Rodríguez Lajusticia L; Villalobos L; Díaz Rubio E
Med Oral Patol Oral Cir Bucal; 2007 Sep; 12(5):E351-6. PubMed ID: 17767097
[TBL] [Abstract][Full Text] [Related]
35. Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.
Walter C; Al-Nawas B; Grötz KA; Thomas C; Thüroff JW; Zinser V; Gamm H; Beck J; Wagner W
Eur Urol; 2008 Nov; 54(5):1066-72. PubMed ID: 18602738
[TBL] [Abstract][Full Text] [Related]
36. Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid.
Olson KB; Hellie CM; Pienta KJ
Urology; 2005 Sep; 66(3):658. PubMed ID: 16140106
[TBL] [Abstract][Full Text] [Related]
37. Bisphosphonate osteonecrosis: a protocol for surgical management.
Markose G; Mackenzie FR; Currie WJ; Hislop WS
Br J Oral Maxillofac Surg; 2009 Jun; 47(4):294-7. PubMed ID: 19231046
[TBL] [Abstract][Full Text] [Related]
38. Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology.
Bedogni A; Blandamura S; Lokmic Z; Palumbo C; Ragazzo M; Ferrari F; Tregnaghi A; Pietrogrande F; Procopio O; Saia G; Ferretti M; Bedogni G; Chiarini L; Ferronato G; Ninfo V; Lo Russo L; Lo Muzio L; Nocini PF
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar; 105(3):358-64. PubMed ID: 18280968
[TBL] [Abstract][Full Text] [Related]
39. Jaw osteonecrosis associated with intravenous bisphosphonate: is incidence reduced after adoption of dental preventive measures?
Fusco V; Baraldi A; Loidoris A; Ciuffreda L; Galassi C; Goia F; Scoletta M; Berrone S; Benech A; Ortega C; Berruti A;
J Oral Maxillofac Surg; 2009 Aug; 67(8):1775. PubMed ID: 19615599
[No Abstract] [Full Text] [Related]
40. Bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
Infante Cossío P; Cabezas Macián A; Pérez Ceballos JL; Palomino Nicas J; Gutiérrez Pérez JL
Med Oral Patol Oral Cir Bucal; 2008 Jan; 13(1):E52-7. PubMed ID: 18167482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]